Acute coronary syndrome (ACS) is an umbrella term for conditions that occur when blood flow to the heart muscle is suddenly reduced or blocked. It encompasses three related emergencies: ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina. All three involve the same underlying problem, a disrupted blood vessel in the heart, but they differ in severity and how much damage they cause.
How ACS Happens Inside Your Arteries
The coronary arteries supply oxygen-rich blood to the heart muscle. Over years, fatty deposits called plaques build up inside these artery walls. Most of the time, these plaques sit quietly. ACS begins when a plaque becomes unstable and ruptures.
The key structural feature that makes a plaque vulnerable is an extremely thin fibrous cap, the layer of tissue holding the plaque together. When that cap tears, it exposes the plaque’s inner contents to the bloodstream. The body treats this like a wound and rapidly forms a blood clot at the site. That clot can partially or completely block the artery, starving the heart muscle of oxygen. Stress hormones that activate the sympathetic nervous system can trigger this rupture, while simultaneously making blood more likely to clot, compounding the problem.
If the blockage is complete, a large section of heart muscle begins to die within minutes. That’s a STEMI. If the blockage is partial, the damage is less extensive but still dangerous. That’s typically an NSTEMI or, in rare cases, unstable angina.
The Three Types of ACS
The distinction between the three types comes down to two things: what an electrocardiogram (ECG) shows and whether heart muscle cells have been damaged.
STEMI is the most severe form. The ECG shows a characteristic pattern called ST-segment elevation, indicating a complete blockage of a coronary artery. Heart muscle is actively dying, and the clock is ticking. Guidelines set a target of 90 minutes from hospital arrival to reopening the artery with a catheter-based procedure.
NSTEMI involves partial blockage. The ECG may show ST-segment depression, inverted T-waves, or sometimes no clear changes at all. However, blood tests reveal elevated troponin, a protein released when heart cells are injured. This confirms that real damage has occurred, even without the dramatic ECG pattern of a STEMI.
Unstable angina was traditionally the mildest form, defined as chest pain with concerning ECG changes but no detectable heart muscle damage. In practice, this diagnosis has become rare. Modern high-sensitivity troponin tests are so precise that they detect tiny amounts of heart injury that older tests missed. Many patients who would have been diagnosed with unstable angina a decade ago are now classified as NSTEMI.
What ACS Feels Like
Chest pain or pressure is the hallmark symptom. People often describe it as a squeezing, heaviness, or tightness in the center or left side of the chest that lasts more than a few minutes, or goes away and comes back. The pain frequently radiates to the left arm, jaw, neck, back, or stomach. Shortness of breath, cold sweats, nausea, and lightheadedness are common alongside the chest discomfort.
Not everyone experiences chest pain, though. Women in particular are more likely to present with what clinicians have called “atypical” symptoms: extreme fatigue, shortness of breath, nausea, or pain in the jaw and back without classic chest pressure. People with diabetes and older adults can also have muted or unusual symptoms. This matters because people who don’t recognize their symptoms as heart-related tend to delay getting help, and in ACS, every minute counts.
How Doctors Confirm the Diagnosis
When someone arrives at the emergency department with symptoms suggesting ACS, two tests happen immediately: an ECG and a blood draw for troponin levels.
The ECG provides the first critical fork in the road. If it shows ST elevation of at least 1 mm in two or more adjacent leads (with slightly higher thresholds in certain chest leads depending on age and sex), the diagnosis is STEMI and treatment begins immediately. For non-STEMI presentations, the ECG may show ST depression of at least 0.5 mm or T-wave inversions, but these changes can be subtle or even absent.
Troponin testing fills in what the ECG can’t show. Current guidelines recommend using high-sensitivity troponin assays, with blood drawn at arrival and again at 1 to 2 hours. If troponin levels rise above the 99th percentile of the normal reference range, or show a rising pattern between the two draws, myocardial infarction is confirmed. This rapid serial testing approach, endorsed by both the American Heart Association and European Society of Cardiology, allows doctors to rule ACS in or out within a couple of hours for most patients.
Emergency Treatment
Treatment depends on the type of ACS, but the overarching goal is the same: restore blood flow and prevent further clotting.
For STEMI, the priority is opening the blocked artery as fast as possible. This is done through a procedure where a catheter is threaded into the coronary artery, the clot is removed or compressed, and a stent is placed to hold the artery open. The gold standard is to complete this within 90 minutes of arriving at the hospital. Every delay beyond that window increases the amount of heart muscle lost.
For NSTEMI, the urgency is real but slightly less immediate. Patients are stabilized with medications first, and the catheter procedure typically happens within 24 to 72 hours, depending on risk factors. Some high-risk NSTEMI patients are taken to the catheterization lab sooner.
Regardless of type, several treatments begin right away. Nitroglycerin helps relieve chest pain by widening blood vessels (though it must be avoided by anyone who has recently taken certain erectile dysfunction medications). Blood-thinning medications are started to prevent the clot from growing. Pain that doesn’t respond to other treatments may be managed with intravenous medications in the hospital.
Blood Thinners After ACS
After the initial emergency, preventing new clots from forming is the central concern. The standard approach is dual antiplatelet therapy, meaning two medications that reduce the blood’s ability to clot, taken together.
The first is low-dose aspirin, typically 81 mg daily. The second is a medication from a class called P2Y12 inhibitors, which block a specific receptor on platelets. Three options exist in this class, and guidelines from the 2025 ACC/AHA update generally favor the newer agents over the older one for ACS patients, as they tend to be more effective at preventing repeat events.
Most people stay on this dual therapy for at least 12 months after their event. The duration can be shortened or extended based on individual bleeding risk versus the risk of another clot. For patients who also need a blood thinner for another condition like atrial fibrillation, the combination becomes more complex, and doctors carefully balance the added bleeding risk.
Risk Factors and Who Gets ACS
The same factors that drive coronary artery disease drive ACS: high blood pressure, high cholesterol, smoking, diabetes, obesity, physical inactivity, and a family history of heart disease. Age is a major factor, with risk climbing significantly for men over 45 and women over 55. Chronic stress and conditions like sleep apnea also contribute.
ACS can strike people who didn’t know they had heart disease. In fact, for many people, a heart attack is the first sign that plaque has been building up in their arteries. This is why controlling the modifiable risk factors matters so much. Quitting smoking, managing blood pressure and cholesterol, staying active, and maintaining a healthy weight all reduce the likelihood that a quiet plaque will become a dangerous one.
What Recovery Looks Like
After an ACS event, most people spend a few days in the hospital. If a stent was placed, the insertion site (usually in the wrist or groin) heals within a week or two. The heart muscle itself needs longer. Damaged areas form scar tissue over several weeks, and the heart gradually adapts to working with whatever muscle remains healthy.
Cardiac rehabilitation, a structured program of supervised exercise, education, and lifestyle coaching, is one of the most effective things you can do after ACS. It improves fitness, reduces the chance of a second event, and helps with the anxiety and depression that commonly follow a heart attack. Most programs run 12 weeks, with sessions two or three times per week.
Long-term, people who have had ACS take several medications indefinitely: a statin to lower cholesterol, a blood pressure medication, low-dose aspirin, and often a beta-blocker to reduce the heart’s workload. These medications, combined with lifestyle changes, substantially lower the risk of a second event. About 1 in 5 people who have a heart attack will have another cardiovascular event within five years, but aggressive risk factor management brings that number down considerably.